Is BNTX up or down today?
BNTX is down 0.70% today, last at 86.92. This stock moved -0.70% versus the prior close.
BNTX · BNTX
BNTX (BNTX) is trading at 86.92, down 0.70% on the session. BNTX sits at the 17% mark of its 52-week range, carries a 14-day RSI of 38, and trades below its 50-day average. Over the past month it is down 10.98%.
Leading the coverage: “Moderna Jumps 4% Despite William Blair Downgrade on Valuation; Novavax and BioNTech Edge Higher - 24/7 Wall St.” (Google News Company, 6d ago). BNTX is -1.22% since story.
BNTX trades on a trailing P/E of 19.2 and is running 8.34% behind the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
BNTX is down 0.70% today, last at 86.92. This stock moved -0.70% versus the prior close.
Leading the coverage: “Moderna Jumps 4% Despite William Blair Downgrade on Valuation; Novavax and BioNTech Edge Higher - 24/7 Wall St.” (Google News Company, 6d ago). BNTX is -1.22% since story. Dominant story: BofA cuts BioNTech stock price target to $108 on model changes - Investing.com UK (1 source, bearish) RSI is 38 — leaning bearish Price below 50-day average — short-term weakness Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: May 2026 – Nov 2026 (125 days) · Drag or scroll left for earlier dates
BofA cuts BioNTech stock price target to $108 on model changes - Investing.com UK
BioNTech SE : Jefferies remains its Buy rating - marketscreener.com
BioNTech (BNTX) Enters First Global Phase 3 Trial For New Breast Cancer Combo - Yahoo Finance
BioNTech SE (BNTX) (Q3 2026) Earnings Call Highlights: Oncology Pipeline Momentum Builds as ... - Yahoo Finance
BioNTech SE (BNTX) (Q3 2026) Earnings Call Highlights: Oncology - GuruFocus